Jacobson Center for Clinical & Translational Research

Main Menu


Additional Information


Contact Us

Brain Cancer Trials

Study Title:  A Randomized, Multicenter, Phase 2 Study of DSP-788 Dosing Emulsion in Combination with Bevacizumab versus Bevacizumab Alone in Patients with Recurrent or Progressive Glioblastoma following Initial Therapy.  (NCT03149003)

Study Purpose:  This is a randomized, active-controlled, multicenter, open-label, parallel groups, Phase 2 study of DSP-7888 Dosing Emulsion plus Bevacizumab versus Bevacizumab alone in patients with recurrent or progressive glioblastoma multiforme (GBM) following treatment with first line therapy consisting of surgery and radiation with or without chemotherapy.

Principal Investigator: Jason Schroeder, MD

Study Coordinator: For more information email Stephanie Smiddy, RN or call 419-383-6962.


Last Updated: 4/26/18